Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 356

1.

Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneity.

Ahn S, Kim HJ, Kang E, Kim EK, Kim SH, Kim JH, Kim IA, Park SY.

Br J Cancer. 2020 Jan 13. doi: 10.1038/s41416-019-0713-1. [Epub ahead of print]

PMID:
31929516
2.

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia.

Shi H, Lee JS, Park SY, Ko Y, Eom JS.

Infect Drug Resist. 2019 Dec 23;12:3925-3934. doi: 10.2147/IDR.S234211. eCollection 2019.

3.

Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer.

Yoon KH, Chae S, Kang E, Shin HC, Kim JH, Kim IA, Park SY, Kim SW, Kim EK.

J Breast Cancer. 2019 Sep 30;22(4):587-598. doi: 10.4048/jbc.2019.22.e47. eCollection 2019 Dec.

4.

Prognostic Role of KRAS mRNA Expression in Breast Cancer.

Hwang KT, Kim BH, Oh S, Park SY, Jung J, Kim J, Choi IS, Jeon SY, Kim WY.

J Breast Cancer. 2019 Dec 2;22(4):548-561. doi: 10.4048/jbc.2019.22.e55. eCollection 2019 Dec.

5.

Prediction of VMAT delivery accuracy with textural features calculated from fluence maps.

Park JM, Kim JI, Park SY.

Radiat Oncol. 2019 Dec 23;14(1):235. doi: 10.1186/s13014-019-1441-7.

6.

Centromere 17 copy number gain reflects chromosomal instability in breast cancer.

Lee K, Kim HJ, Jang MH, Lee S, Ahn S, Park SY.

Sci Rep. 2019 Nov 29;9(1):17968. doi: 10.1038/s41598-019-54471-w.

7.

HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation.

Ahn S, Woo JW, Lee K, Park SY.

J Pathol Transl Med. 2020 Jan;54(1):34-44. doi: 10.4132/jptm.2019.11.03. Epub 2019 Nov 6. Review.

8.

A Multi-institutional Study of Prevalence and Clinicopathologic Features of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) in Korea.

Seo JY, Park JH, Pyo JY, Cha YJ, Jung CK, Song DE, Kwak JJ, Park SY, Na HY, Kim JH, Seok JY, Kim HS, Hong SW.

J Pathol Transl Med. 2019 Nov;53(6):378-385. doi: 10.4132/jptm.2019.09.18. Epub 2019 Oct 21.

9.

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem.

Park SY, Si HJ, Eom JS, Lee JS.

J Int Med Res. 2019 Dec;47(12):5977-5985. doi: 10.1177/0300060519879336. Epub 2019 Oct 15. No abstract available.

PMID:
31612764
10.

Preoperative Diagnostic Categories of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Thyroid Core Needle Biopsy and Its Impact on Risk of Malignancy.

Na HY, Woo JW, Moon JH, Choi JY, Jeong WJ, Kim YK, Choe JY, Park SY.

Endocr Pathol. 2019 Dec;30(4):329-339. doi: 10.1007/s12022-019-09590-5.

PMID:
31605276
11.

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value.

Woo JW, Chung YR, Ahn S, Kang E, Kim EK, Kim SH, Kim JH, Kim IA, Park SY.

J Breast Cancer. 2019 Sep 2;22(3):439-452. doi: 10.4048/jbc.2019.22.e38. eCollection 2019 Sep.

12.

An oncogenic activity of PDGF-C and its splice variant in human breast cancer.

Bottrell A, Meng YH, Najy AJ, Hurst N Jr, Kim S, Kim CJ, Kim ES, Moon A, Kim EJ, Park SY, Kim HC.

Growth Factors. 2019 Aug;37(3-4):131-145. doi: 10.1080/08977194.2019.1662415. Epub 2019 Sep 23.

PMID:
31542979
13.

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.

Ding L, Su Y, Fassl A, Hinohara K, Qiu X, Harper NW, Huh SJ, Bloushtain-Qimron N, Jovanović B, Ekram M, Zi X, Hines WC, Alečković M, Gil Del Alcazar C, Caulfield RJ, Bonal DM, Nguyen QD, Merino VF, Choudhury S, Ethington G, Panos L, Grant M, Herlihy W, Au A, Rosson GD, Argani P, Richardson AL, Dillon D, Allred DC, Babski K, Kim EMH, McDonnell CH 3rd, Wagner J, Rowberry R, Bobolis K, Kleer CG, Hwang ES, Blum JL, Cristea S, Sicinski P, Fan R, Long HW, Sukumar S, Park SY, Garber JE, Bissell M, Yao J, Polyak K.

Nat Commun. 2019 Sep 13;10(1):4182. doi: 10.1038/s41467-019-12125-5.

14.

The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.

Park SY, Lee CJ, Choi JH, Kim JH, Kim JW, Kim JY, Nam JS.

J Exp Clin Cancer Res. 2019 Sep 11;38(1):399. doi: 10.1186/s13046-019-1405-7.

15.

Characterization of radiochromic films as a micrometer-resolution dosimeter by confocal Raman spectroscopy.

Mirza JA, Hernández Millares R, Kim GI, Park SY, Lee J, Ye SJ.

Med Phys. 2019 Nov;46(11):5238-5248. doi: 10.1002/mp.13778. Epub 2019 Sep 13.

PMID:
31442302
16.

Computed Tomography for Detecting Cervical Lymph Node Metastasis in Patients Who Have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance.

Lee DH, Kim YK, Yu HW, Choi JY, Park SY, Moon JH.

Thyroid. 2019 Nov;29(11):1653-1659. doi: 10.1089/thy.2019.0100. Epub 2019 Sep 26.

PMID:
31436140
17.

Benign Breast Papilloma without Atypia: Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up.

Choi HY, Kim SM, Jang M, Yun B, Kang E, Kim EK, Park SY, Kim B, Cho N, Moon WK.

Radiology. 2019 Oct;293(1):72-80. doi: 10.1148/radiol.2019190096. Epub 2019 Aug 20.

PMID:
31429678
18.

Ultimate Charge Extraction of Monolayer PbS Quantum Dot for Observation of Multiple Exciton Generation.

Park SY, Han S, Kim Y, Jung S, Kim DH, Han GS, Jung HS.

Chemphyschem. 2019 Oct 16;20(20):2657-2661. doi: 10.1002/cphc.201900381. Epub 2019 Sep 11.

PMID:
31410971
19.

Modeling scattered radiation from multi-leaf collimators (MLCs) to improve calculation accuracy of in-air output ratio.

Park SY, Kim S, Sung W, Kim ST.

Australas Phys Eng Sci Med. 2019 Sep;42(3):719-731. doi: 10.1007/s13246-019-00781-2. Epub 2019 Jul 22.

20.

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.

Park SY, Choi JH, Nam JS.

Cancers (Basel). 2019 Jul 9;11(7). pii: E965. doi: 10.3390/cancers11070965. Review.

Supplemental Content

Loading ...
Support Center